Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cathcart

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Journal of Lipid Research|September 1, 1994
Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDLV A Folcik, M K Cathcart
The Journal of Clinical Investigation|April 1, 1993
Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytesQ Li, A Tallant, M K Cathcart
Hybridoma|December 1, 1988
Human hybridoma suppressor factor (HSF) inhibits IL2 production in addition to suppressing immunoglobulin productionM Murakami, Y Tomita, M K Cathcart
The Journal of Biological Chemistry|August 13, 2003
Human monocytes use Rac1, not Rac2, in the NADPH oxidase complexXiaoxian Zhao, Kevin A Carnevale, Martha K Cathcart
Blood Reviews|September 30, 2000
CML vaccines as a paradigm of the specific immunotherapy of cancerJ Pinilla-Ibarz, K Cathcart, D A Scheinberg
Immunobiology|August 1, 1990
Selective suppression of lymphokine production by human hybridoma suppressor factor (HSF)Y Tomita, B Y Lieberman, M K Cathcart
The Journal of the American Osteopathic Association|August 1, 1990
Effect of culture-medium temperature on growth of Neisseria gonorrhoeaeS K Cathcart, M Austin, M L Nowak
Journal of Lipid Research|September 1, 1995
Lipoprotein receptor interactions are not required for monocyte oxidation of LDLM K Cathcart, Q Li, G M Chisolm
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Cytokine modulation of LDL oxidation by activated human monocytesV A Folcik, R Aamir, M K Cathcart
Immunopharmacology|November 1, 1988
Human hybridoma suppressor factor acts selectively on CD4+ cellsY Tomita, M M Dustoor, M K Cathcart
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Journal of Lipid Research|September 1, 1994
Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDLV A Folcik, M K Cathcart
The Journal of Clinical Investigation|April 1, 1993
Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytesQ Li, A Tallant, M K Cathcart
Hybridoma|December 1, 1988
Human hybridoma suppressor factor (HSF) inhibits IL2 production in addition to suppressing immunoglobulin productionM Murakami, Y Tomita, M K Cathcart
The Journal of Biological Chemistry|August 13, 2003
Human monocytes use Rac1, not Rac2, in the NADPH oxidase complexXiaoxian Zhao, Kevin A Carnevale, Martha K Cathcart
Blood Reviews|September 30, 2000
CML vaccines as a paradigm of the specific immunotherapy of cancerJ Pinilla-Ibarz, K Cathcart, D A Scheinberg
Immunobiology|August 1, 1990
Selective suppression of lymphokine production by human hybridoma suppressor factor (HSF)Y Tomita, B Y Lieberman, M K Cathcart
The Journal of the American Osteopathic Association|August 1, 1990
Effect of culture-medium temperature on growth of Neisseria gonorrhoeaeS K Cathcart, M Austin, M L Nowak
Journal of Lipid Research|September 1, 1995
Lipoprotein receptor interactions are not required for monocyte oxidation of LDLM K Cathcart, Q Li, G M Chisolm
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Cytokine modulation of LDL oxidation by activated human monocytesV A Folcik, R Aamir, M K Cathcart
Immunopharmacology|November 1, 1988
Human hybridoma suppressor factor acts selectively on CD4+ cellsY Tomita, M M Dustoor, M K Cathcart
Pageof 9